Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression.
Kemper M, Schiecke A, Maar H, Nikulin S, Poloznikov A, Galatenko V, Tachezy M, Gebauer F, Lange T, Riecken K, Tonevitsky A, Aigner A, Izbicki J, Schumacher U, Wicklein D. Kemper M, et al. Among authors: galatenko v. J Exp Clin Cancer Res. 2021 Jun 26;40(1):214. doi: 10.1186/s13046-021-01946-2. J Exp Clin Cancer Res. 2021. PMID: 34174926 Free PMC article.
Knockdown of L1CAM significantly reduces metastasis in a xenograft model of human melanoma: L1CAM is a potential target for anti-melanoma therapy.
Ernst AK, Putscher A, Samatov TR, Suling A, Galatenko VV, Shkurnikov MY, Knyazev EN, Tonevitsky AG, Haalck T, Lange T, Maar H, Schröder-Schwarz J, Riecken K, Schumacher U, Wicklein D. Ernst AK, et al. Among authors: galatenko vv. PLoS One. 2018 Feb 12;13(2):e0192525. doi: 10.1371/journal.pone.0192525. eCollection 2018. PLoS One. 2018. PMID: 29432466 Free PMC article.
Xenograft-derived mRNA/miR and protein interaction networks of systemic dissemination in human prostate cancer.
Lange T, Samatov TR, Galatenko VV, Steffen P, von Kriegstein H, Spethmann T, Wicklein D, Maar H, Kupfernagel K, Labitzky V, Hanika S, Starzonek S, Ahlers AK, Riecken K, Simon R, Polonski A, Sauter G, Schlomm T, Huland H, Johnsen SA, Schlüter H, Tonevitsky AG, Schumacher U. Lange T, et al. Among authors: galatenko vv. Eur J Cancer. 2020 Sep;137:93-107. doi: 10.1016/j.ejca.2020.06.025. Epub 2020 Aug 1. Eur J Cancer. 2020. PMID: 32750503 Free article.
Novel biomarkers in cancer: The whole is greater than the sum of its parts.
Samatov TR, Galatenko VV, Block A, Shkurnikov MY, Tonevitsky AG, Schumacher U. Samatov TR, et al. Among authors: galatenko vv. Semin Cancer Biol. 2017 Aug;45:50-57. doi: 10.1016/j.semcancer.2016.09.002. Epub 2016 Sep 14. Semin Cancer Biol. 2017. PMID: 27639751 Review.
miRNome of inflammatory breast cancer.
Maltseva DV, Galatenko VV, Samatov TR, Zhikrivetskaya SO, Khaustova NA, Nechaev IN, Shkurnikov MU, Lebedev AE, Mityakina IA, Kaprin AD, Schumacher U, Tonevitsky AG. Maltseva DV, et al. Among authors: galatenko vv. BMC Res Notes. 2014 Dec 4;7:871. doi: 10.1186/1756-0500-7-871. BMC Res Notes. 2014. PMID: 25471792 Free PMC article.
Cumulative prognostic power of laminin genes in colorectal cancer.
Galatenko VV, Maltseva DV, Galatenko AV, Rodin S, Tonevitsky AG. Galatenko VV, et al. Among authors: galatenko av. BMC Med Genomics. 2018 Feb 13;11(Suppl 1):9. doi: 10.1186/s12920-018-0332-3. BMC Med Genomics. 2018. PMID: 29504916 Free PMC article.
36 results